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ABSTRACT
Whooping cough, or pertussis, is resurgent in numerous countries worldwide. This has renewed interest in Bordetella
pertussis biology and vaccinology. The in vitro growth of B. pertussis has been a source of difficulty, both for the study
of the organism and the production of pertussis vaccines. It is inhibited by fatty acids and other hydrophobic
molecules. The AcrAB efflux system is present in many different bacteria and in combination with an outer membrane
factor exports acriflavine and other small hydrophobic molecules from the cell. Here, we identify that the speciation
of B. pertussis has selected for an Acr system that is naturally mutated and displays reduced activity compared to
B. bronchiseptica, in which the system appears intact. Replacement of the B. pertussis locus with that of
B. bronchiseptica conferred higher levels of resistance to growth inhibition by acriflavine and fatty acids. In addition,
we identified that the transcription of the locus is repressed by a LysR-type transcriptional regulator. Palmitate de-
represses the expression of the acr locus, dependent on the LysR regulator, strongly suggesting that it is a
transcriptional repressor that is regulated by palmitate. It is intriguing that the speciation of B. pertussis has selected
for a reduction in activity of the Acr efflux system that typically is regarded as protective to bacteria.
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Introduction
The genus Bordetella consists of nine characterized
species (recently other novel species have been
reported), including those that cause respiratory infec-
tions. B. pertussis is a fastidious, Gram-negative cocco-
bacillus that is a strict pathogen of humans that causes
whooping cough or pertussis. B. pertussis has evolved
recently from B. bronchiseptica or a B. bronchiseptica-
like ancestor [1]. This speciation involved considerable
genome reduction and rearrangement that resulted in
an organism restricted to the human respiratory
tract. In comparison, B. bronchiseptica has a broad
host range and grows freely in the environment [2,3].
Pertussis is considered resurgent in many parts of the
world, despite high levels of vaccination. Possible
reasons for this have been well discussed (reviewed in
[4–7]). Resurgence has emphasized sizeable gaps in
the understanding of the mechanisms of B. pertussis
pathogenesis and of B. pertussis physiology. In vitro,
growth of B. pertussis has proved challenging,
especially in liquid culture. B. pertussis is unable to
metabolize sugars, appearing reliant on the metabolism
of amino acids [8,9]. Glutamate and proline are the
most readily oxidized and glutamate has been used as
the primary carbon and nitrogen source in most
defined B. pertussis growth media, for example Stai-
ner–Scholte (SS) broth [9]. B. pertussis is unable to
grow in some media, even though they contain sources
of glutamate, for example on Luria–Bertani agar, due to
the presence of compounds inhibitory to growth.
B. pertussis is sensitive to a number of compounds
including peptone, fatty acids, sulphur, peroxide, and
manganese [10]. Often, charcoal, blood, or cyclodex-
trins are added to B. pertussis growth media to seques-
ter hydrophobic inhibitory compounds. In particular,
growth of B. pertussis is inhibited by a number of
fatty acids including palmitic acid (16:0) [10]. How-
ever, in the commonly used laboratory media
B. pertussis releases fatty acids, particularly palmitic
acid, into the culture supernatant to concentrations
that inhibit growth [11]. This contributes to a poor
yield from in vitro B. pertussis cultures and to issues
with reproducibility of the quality of the biomass pro-
duced, creating major problems for vaccine manufac-
turers. This will be particularly challenging for
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B. pertussis acr is mutated.
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increasing vaccine production as part of any interven-
tion to combat resurgence.
Many bacteria possess mechanisms to resist the
inhibitory effects of small hydrophobic molecules, for
example the AcrAB-TolC efflux system of Escherichia
coli that is responsible for resistance to a wide range of
hydrophobic inhibitors [12]. This system consists of
an inner membrane transporter AcrA, a periplasmic
coupling protein, AcrB, that couples AcrA to TolC,
the outer membrane channel [13,14]. In addition,
E. coli AcrZ associates with AcrB to enhance the export
of some substrates [15]. Here, we report that the
B. pertussis acrAB-cusC (acrABC) locus contains two
small deletions, resulting in low activity of B. pertussis
AcrABC compared to the B. bronchiseptica system.
We demonstrate that Bordetella AcrABC confers resist-
ance to inhibition of growth by acriflavine and fatty
acids and that a LysR-type transcriptional regulator
represses transcription of acrABC, repression that is alle-
viated by the substrate palmitate.
Materials and methods
Bacterial strains and culture conditions
Bacterial strains used in this study are listed in Table 1.
Plasmids used in this study are listed in Table 2. BP536
is a single passage, streptomycin resistant derivative of
Tohama I and used as WT in this study. B. pertussis
was cultured on charcoal agar (CA) (Fisher Scientific,
Loughborough, UK) for 3 days at 37°C or in Stainer–
Scholte broth (SS) or in SSH (SS with 1 g/L heptakis
[9] (Sigma-Aldrich, Gillingham, UK)) at 37°C with
shaking at 180 rpm. E. coli were grown on LB agar or
in LB broth at 37°C. Antibiotics were used where
appropriate at the following concentrations: kanamy-
cin 50 µg/ml and gentamycin 30 µg/ml. For growth
of E. coli ST18 [16] media was supplemented with
amino-levulinic acid at 50 µg/ml.
PCR
PCR was conducted using OneTaq 2x master mix
(NEB, Hitchin, UK) following the manufacturer’s
instructions modified to include 0.75 µl of DMSO per
reaction. The cycle conditions were as follows: 94°C
for 4 min followed by 30 cycles of 94°C for 30 s, anneal-
ing for 1 min, 68°C for 1 min/kb and 5 min at 68°C.
Details for the primers used can be found in Table 3.
Mutagenesis
Deletions of acrABC and BP0983 were created by
amplifying by PCR approximately 500 bp of the
regions flanking the deletions. For acrABC, these flank-
ing regions were cloned either side of a kanamycin
resistance cassette to produce acrDELKanABpSS4940.
For deletion of BP0983, the flanking regions were
joined together to create an in-frame deletion of
BP0983. PCR fragments were cloned into pSS4940GG
by Golden Gate cloning [17]. Constructs were trans-
formed into chemically competent E. coli ST18,
which was subsequently used as the donor for conju-
gation. Conjugations were carried out as previously
described [18]. Conjugants were selected on charcoal
agar supplemented with gentamycin and 50 mM
MgSO4. Following counter-selection against merodi-
ploids, deletion mutants were distinguished from WT
by PCR. For replacement of the B. pertussis acr locus
with that of B. bronchiseptica, B. bronchiseptica locus
was amplified by PCR as two sections and ligated
together using Gibson Assembly. The resulting locus
fragment was cloned into pSS4940GG as above and
conjugated into BPΔacrABC.
Inhibition assays
Plate grown B. pertussis strains were resuspended in SS
to an OD600 of 0.1 and grown overnight. Cultures were
diluted in fresh SS supplemented with different con-
centrations of the inhibitory compound: acriflavine,
palmitic acid, myristic acid, oleic acid, and decanoic
Table 1. Strains used in this study.
Strain Description Reference
B. pertussis BP536 WT [30]
B. bronchiseptica
RB50
WT [31]
E. coli ST18 S17 λpir ΔhemA [16]
E. coli NEB5α Cloning strain NEB
BPΔ0983 Deletion of BP0983 This study
BPΔacrABC Deletion of acrA-C This study
BPacrABCBB Allelic replacement of BPacrABC with
B. bronchiseptica acrABC
This study
BPacrABCBBΔ0983 Deletion of BP0983 in BPacrABCBB This study
BPpBBRK Wild-type containing pBBRK This study
BPacrABCBBpBBRK Wild-type containing pBBRKacrABCBB This study
Table 2. Plasmids used in this study.
Name Description Source or reference
pSS4940 pSS4245-based suicide plasmid (GmR) [32]
pSS4940GG pSS4245-based suicide plasmid modified for Golden Gate cloning (GmR, CmR) This study
pBBRK pBBR-based shuttle vector, KanR [33]
pBBRKGG pBBRK shuttle vector modified for Golden Gate cloning (KanR, CmR) This study
pSS49400983AB pSS4940 containing upstream and downstream fragments of BP0983 for allelic exchange This study
pBBRKacrABCBB pBBRK containing BB2526-acrABCBB This study
pSS4940acrDelK pSS4940 containing 5’ fragment of acrA, KanR cassette and 3’ fragment of acrC This study
pSS4940acrABCBB pSS4940 containing BB2526-acrABC This study
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acid (Sigma-Aldrich, BioXtra grade). Cultures (200 μl)
were incubated at 37°C with shaking at 200 rpm in
microtitre plates. After 3 days, the OD600 was measured
in a Fluostar Omega plate reader (BMG LabTech,
Aylesbury, UK). The OD600 of cultures grown in the
presence of inhibitor was divided by the OD600 of the
same strain grown without inhibitor to give relative
growth as a percentage. Resistance to ampicillin was
determined using E-test strips in accordance with man-
ufacturer’s instructions (Biomerieux, Basingstoke, UK).
Plates were inoculated with 100 µl of a suspension of
bacteria at OD600 = 0.8 (∼1.5 × 108 cfu/ml).
RT-qPCR
Bacteria were grown overnight in SS or SSH and these
cultures were used to inoculate fresh media at an
OD600 of 0.05. Cultures were harvested at OD600 = 0.9
± 0.1 by centrifugation (4000g for 10 min) and resus-
pended in 700 µl of Tri-reagent (Invitrogen; Thermo-
Fisher, Loughborough, UK), vortexed vigorously, and
frozen at −80°C. Nucleic acids were precipitated with
ethanol, DNA was removed using 4U of Turbo DNase
(Ambion, ThermoFisher) for 1 h, and RNA was purified
using the RNeasy kit (Qiagen, Manchester, UK) in
accordance with the manufacturer’s instructions. The
concentration of RNA was determined using Qubit
broad range RNA quantification kit (Fisher Scientific).
RNA integrity was determined by agarose gel electro-
phoresis. Finally, RNA was confirmed as being DNA
free by PCR using 50 ng of RNA as template in PCR
with recAF and recAR primers. First strand cDNA was
synthesized using ProtoScript II (NEB) with 1 µg of
total RNA as template and 6 µM random primers and
incubated for 5 min at 25°C, 1 h at 42°C. The reaction
was stopped by incubating at 65°C for 20 min. cDNA
was diluted 1/30 in H2O for use in qPCR.
qPCR was run on an a StepOne Real-time PCR Sys-
tem (Applied Biosystems, ThermoFisher) using
SyberGreen Turbo Master mix (Applied Biosystems),
in a total reaction volume of 25 µl with primers at
300 nM. Triplicate reactions were run for each sample.
Reactions conditions were: 95°C for 10 min and 40
cycles of 95°C for 15 s and 1 min at 60°C. The house-
keeping gene recA was used to calculate ΔCT and
ΔΔCT was determined by determining the difference
between the reference condition and experimental con-
dition. Relative expression was represented as fold
change (fold change = 2−ΔΔCT). Three biological
repeats were used for each experiment. Significance
was determined using Students t-test using a hypothe-
tical value of 1 (no relative expression difference).
Ethidium bromide accumulation assay [19,20]
B. pertussis strains were grown in SS until OD600 = 1.00
± 0.1. Ethidium bromide was added at 16 µM. Samples
were vortexed and transferred to a 96-well plate, stored
in the dark for 30 min before fluorescence was
measured in a FLOUstar Optima microplate reader
(BMG Labtech). Variation in OD600 was accounted
for by dividing the fluorescence value by the OD600
and expressed as relative fluorescence.
Modelling the structure of BP0983
This was conducted using I-TASSER under default set-
tings [21]. The C-score of the model produced by I-TAS-
SER was determined by comparison to a number of
similar protein sequences the most similar to BP0983
was CrgA Protein Data Bank number 3hhgE [22].
Model images were made using CHIMERA 1.13.1 [23].
Results
Deletions in acrA and cusC in B. pertussis results
in inhibition of growth on LB agar
B. pertussis is sensitive to free fatty acids and other hydro-
phobic molecules, and its growth is limited on rich media
Table 3. Primers used in this study.
Primer Sequence 5’–3’ Annealing temp (°C) Comment
0983AF AAAAGGTCTCTCGAGAGAACAGGCGCTTCTGGAC 52 BP0983 mutagenesis
0983AR AAAAGGTCTCGATGTGGAGTTCCATGCCTTGCAAAC 52 BP0983 mutagenesis
0983BF AAAAGGTCTCTACATAACACTGGCAGGCCAGAATAA 54 BP0983 mutagenesis
0983BR AAAAGGTCTCGAACTACTGGTCCTCACGCAGGAT 54 BP0983 mutagenesis
acrDelAF AAAAAAGGTCTCTCTAGAGCAAACGGTTCATGGCGGATG 58 acrBP deletion
acrDelAR AAAAAAAGGTCTCCATATGAGCAAGGTGGCGGTCTTCA 58 acrBP deletion
acrDelBF AAAAAAGGTCTCAGATCTACAACGCCTACCTGACCCTG 58 acrBP deletion
acrDel BR AAAAAAGGTCTCGAATTCGCGATGCCGATATCCTTCTG 58 acrBP deletion
KanF AAAAAAGGTCTCCATATGACGTCTTGTGTCTCAAAATCTC 45 Amplification of KanR
KanR AAAAAAGGTCTCAGATCTTAGAAAAATTCAATCCAGCATC 45 Amplification of KanR
BB2526/acrABCF ACAAAAAAGCAGGCTCCGAATTCTTAACGCAAATTTAAAAACGCC 53 Amplification of BB2526/acrABC BB
BB2526/acrABCFR GGGACAACAAGGTTCTCATGACGGCAGGT 53 Amplification of BB2526/acrABC BB
BBcusCF CATGAGAACCTTGTTGTCCCTTG 53 Amplification of acrCBB
BBcusCR CAAGAAAGCTGGGTCGAATTTCATCGTGTTGTTCGTCGT 53 Amplification of acrC BB
acrAq1F CTTTCCTTGGCGGCATTGAC 60 qPCR of acrA
acrAq1R CGACTGGGTTTTCAGGGTGA 60 qPCR of acrA
recAqF AACCAGATCCGCATGAAGAT 60 qPCR of recA
recAqR ACCTTGTTCTTGACCACCTT 60 qPCR of recA
0983qF CCTGGCCATTCCCAAATCCA 60 qPCR of BP0983
0983qR TGGCAGCGCTCGAAGTAAAG 60 qPCR of BP0983
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including Luria–Bertani media [24], whereas
B. bronchiseptica is less sensitive. During comparisons
of genome sequences of B. pertussis Tohama I and
B. bronchiseptica RB50, it was noticed that while both
species contain homologues of acrAB-tolC genes, the
B. pertussis system contains two mutations. Compared
to B. bronchiseptica, B. pertussis acrA (BP0984) contains
a 646 bp deletion of the 3’ region of the gene, predicted
to result in a truncated AcrA that due to a frameshift cre-
ated by the deletion contains different carboxyl-terminal
amino acids to that of B. bronchiseptica AcrA. Also,
there is an 84 bp in-frame deletion in BP0986, originally
annotated as cusC, compared to the homologue in
B. bronchiseptica, which we predict to encode the outer
membrane factor of the efflux system, and refer to here
as acrC (Figure 1a). Aside from these two deletions, the
two loci are highly homologous. There are just five
amino acid differences between the two AcrB proteins
(1059 amino acids) and (outside of the 28 amino acid del-
etion) one amino acid difference between the two AcrC
proteins. Furthermore, these deletions are conserved
across all currently available B. pertussis genome
sequences, indicating that these deletions were likely
acquired early in the evolution of B. pertussis. We hypoth-
esized that B. pertussis contains a non-functional Acr
efflux system whereas it is functional in
B. bronchiseptica. To test this, the B. bronchiseptica
locus (BB2527-9), including the adjacent gene encoding
a putative LysR-type transcriptional regulator (BB2526)
carried on pBBRK, a plasmid that replicates in Bordetella,
was introduced into B. pertussis to produce
BPpBBRKacrABCBB. Also, acrA-C were deleted from
B. pertussis and replaced with a kanamycin resistance cas-
sette to produce BPΔacrABC. This strain was used as a
background to clone the B. bronchiseptica locus onto
the chromosome in place of the kanamycin cassette, effec-
tively replacing the B. pertussis acr locus with that of
B. bronchiseptica, producing BPacrABCBB.
The ability of each strain to grow on LB agar was
assessed. WT B. pertussis, WT containing pBBRK plas-
mid alone, and BPΔacrABC were unable to grow on LB
agar, in contrast to both BPpBBRKacrABCBB and
BPacrABCBB (Figure 1b), suggesting that the inability
of B. pertussis to grow on LB is caused by the deletions
in BPacrA and BPacrC.
B. pertussis AcrABC retains residual function
The relative activities of the B. pertussis and
B. bronchiseptica Acr systems were investigated by
assaying the accumulation of ethidium bromide within
strains, that in other bacteria is effluxed by Acr [19,20].
High levels of bacterial fluorescence were indictive of a
low level of efflux of ethidium bromide, and this was
represented relative to WT to control for variation in
fluorescence between experiments (Figure 1c). BPΔa-
crABC accumulated more ethidium bromide than
WT (22% greater than WT, p = 0.026), indicating
that the deletion of acrABC decreased efflux of ethi-
dium bromide. This suggested that B. pertussisAcrABC
retains some function, despite the two mutations. The
presence of the B. bronchiseptica locus resulted in sig-
nificantly less accumulation of ethidium bromide
(24% less than WT, p = 0.021) demonstrating that the
B. bronchiseptica system has greater activity for efflux
of ethidium bromide than that of B. pertussis.
BP0983 is a transcriptional repressor of acrABC
Adjacent to, but divergent from, acrABC in both
B. pertussis and B. bronchiseptica is a gene encoding a
putative LysR family transcriptional regulator
(BP0983 and BB2526 respectively, Figure 1). Genes
encoding this class of regulator are often situated
upstream of, and divergent from, the genes that they
regulate [25]. The predicted structure of BP0983 con-
tains two conserved domains, an N-terminal helix-
turn-helix (HTH) domain found in LysR family pro-
teins (pfam00126) and a LysR substrate binding
domain (pfam03466) (Figure 2a). An N-terminal
HTH is the characteristic of LysR-type transcriptional
regulators that act as transcriptional repressors.
To test the involvement of BP0983 in regulating acr
expression, BP0983 was deleted from B. pertussis in
both the WT and BPacrABCBB backgrounds, produ-
cing BPΔ0983 and BPacrABCBBΔ0983 respectively.
The relative level of transcription of acrA in WT and
BPΔ0983 was measured using RT-qPCR. Strains were
grown in SS broth either with or without heptakis.
Heptakis is a cyclodextrin used to supplement
B. pertussis growth media by sequestering small hydro-
phobic molecules that are inhibitory to B. pertussis
growth. WT grown with heptakis was used as the refer-
ence condition. Compared to this, there was a 4.1-fold
increase in the expression of acrA in WT when grown
in SS without heptakis (Figure 2b). B. pertussis growing
in SS broth produces free fatty acids that are seques-
tered by heptakis when present in the medium [11].
The increased transcription of acrA in the absence of
heptakis, and thus in the presence of free fatty acids
in the culture medium, is consistent with the notion
that free fatty acids signal to increase transcription of
acr. In BPΔ0983, transcription of acrA was increased,
and this was insensitive to the presence or absence of
heptakis (2.5-fold with heptakis and 2.8-fold without
heptakis, relative to WT).
Deletion of BP0983 resulted in increased levels of
transcription of acrA, but regardless of the presence
or absence of heptakis, and thus of the presence of
fatty acids in the culture medium. This supports the
idea that BP0983 is a transcriptional repressor of
acrABC and that fatty acids derepress transcription.
However, deletion of BP0983 would be expected to
completely relieve repression of acrA transcription
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Figure 1. B. pertussis acr is mutated and has lower activity than B. bronchiseptica acr. (a) Diagram showing the arrangement of the
B. pertussis and B. bronchiseptica acrABC loci. BP0983/BB2526 encodes a LysR-type transcriptional regulator. B. pertussis acrA and
acrC (cusC) have 646 and 84 bp (in-frame) deletions respectively, compared to B. bronchiseptica. (b) B. pertussis strains were plated
on charcoal agar (left) and LB agar (right). All strains grew on charcoal agar. WT, WT containing pBBRK (BPpBBRK) and BPΔacrABC
were unable to grow on LB agar whereas the presence of acrABCBB conferred growth on LB. (c) An ethidium bromide accumulation
assay was used to measure AcrABC activity. acrABCBB conferred greater efflux activity compared to that attributable to the
B. pertussis locus. Deletion of acrABC from B. pertussis resulted in decreased activity suggesting B. pertussis AcrABC has residual
function. The data is based on six independent experiments. Error bars represent standard deviation and significance was deter-
mined by a one-sample t-test comparing each strain to WT. *: p < 0.05; **: p < 0.01.
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and it is not clear why the level of expression of acrA in
BPΔ0983 was not as high as in WT grown in SSH,
suggesting that there may be a synergistic repressor
activity by something that is sequestered by heptakis.
The role of Acr in resistance to acriflavine,
ampicillin and fatty acids
E. coli AcrAB-TolC expels acriflavine and other small
hydrophobic molecules from the cell. To test the
activity of Bordetella Acr against such compounds,
the sensitivity of strains to acriflavine, ampicillin and
fatty acids was tested. BPΔacrABC proved difficult to
grow in broth in the absence of heptakis. The inability
to grow this strain in the absence of heptakis, that
might sequester the test compounds, precluded it
from being included in these assays.
The growth of strains over 48 h in the presence of
different concentrations of acriflavine was measured
and normalized to growth without acriflavine. There
was no significant difference between growth of any of
the strains at ≤4 µg/ml acriflavine. However, at 8 µg/
ml the growth of BPacrABCBBΔ0983 was significantly
greater than any of the other strains (Figure 3a). These
data suggest that B. pertussis AcrABC could efflux
acriflavine, but with low activity as growth of
BPΔ0983, in which the expression of the system was
higher, was no different to WT. The increased growth
of BPacrABCBB suggests that the B. bronchiseptica
locus conferred increased resistance to acriflavine but
only when repression of its transcription was relieved
by deletion of BP0983. In turn, this suggested that
although acriflavine was a substrate of Acr, it was unable
to induce relief of BP0983-mediated repression.
The role of Acr in resistance to ampicillin was tested
using E-test strips. The MIC for WT was 0.094 µg/ml.
The MIC for BPΔacrABC (0.19 µg/ml) and for
BPΔ0983 (0.25 µg/ml) was not largely different to that
of WT. The MICs of BPacrABCBB (16 µg/ml) and
BPacrABCBBΔ0983 (>256 µg/ml) suggested that the
B. bronchiseptica locus conferred significantly increased
resistance to ampicillin, and that the sensitivity of
B. pertussis to ampicillin may, at least in part, be due to
the low activity of B. pertussis Acr.
Palmitate is the main fatty acid released by
B. pertussis during growth [11]. The role of Acr in
the sensitivity of B. pertussis to palmitate was investi-
gated (Figure 3b). There was no difference between
the growth of strains in the presence of palmitate up
to 4 µg/ml. Above this level, the growth of strains con-
taining acrABCBP was inhibited, even if transcription of
it was derepressed (BPΔ0983). There was a significant
difference in the growth of BPacrABCBB in the presence
of palmitate compared to both WT and BPΔ0983,
demonstrating that AcrABCBB conferred much higher
levels of resistance to growth inhibition by palmitate
than AcrABCBP (Figure 5B). There was a significant
difference in growth between BPacrABCBB and
BPacrABCBBΔ0983 at both 32 and 48 µg/ml of palmi-
tate (Figure 3b), consistent with the deletion
of BP0983 increasing the level of expression of
acrABCBB.
Figure 2. BP0983 is a transcriptional repressor of acrABC. (a) Diagram of the conserved domains of the LysR-family transcriptional
regulator encoded by BP0983. A predicted helix-turn-helix motif (green) at the N-terminus is indicative of repressor activity. It also
contains a LysR substrate domain (blue). (b) Expression of acrA determined by RT-qPCR. Growth of WT in SS broth with heptakis
(SSH) was the reference condition for comparison on the left of the dotted line, and BPΔ0983 in SSH on the right. There was a
significant increase in expression of acrA in WT in SS broth without heptakis (WT-SS) and BPΔ0983 SSH (BPΔ0983-SSH) with a
fold change of 4.1 and 2.5 respectively. There was no difference between acrA expression in BPΔ0983 in SS compared to SSH.
The data is based on three biological repeats. Error bars represent standard deviation and significance was determined by one-
sample t-test comparing each condition to the reference.
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To determine the range of fatty acids that are sub-
strates for AcrABC, growth in the presence of decanoic
acid (C10:0), myristic acid (C14:0), and oleic acid
(C18:1) was tested (Figure 3c–e). There was a similar
pattern of resistance to that observed with palmitate in
that AcrABCBB conferred higher levels of resistance
than AcrABCBP and deletion of BP0983 increased
further the resistance conferred by AcrABCBB, although
this increase was not always significant. The data
suggested that short chain fatty acids inhibited the
growth of B. pertussis less than longer chain fatty acids.
BP0983 contains a potential fatty acid
binding site
Bordetella AcrABC was active against a range of fatty
acids, and B. pertussis releases palmitate during its
growth in vitro. We hypothesized that fatty acids sig-
nalled to increase expression of acrABC by binding to
BP0983 to relieve its repression of acrABC.A structural
model of BP0983 was produced using I-TASSER [21]
(Figure 4). The model had a high C-score (0.42) and
a TM-score (0.77 ± 0.10), which was indicative of a rea-
listic prediction of the structure of BP0983. This struc-
ture was consistent with that of LysR transcriptional
regulators, comprising a DNA binding domain, a
hinge domain that allows for a conformational change
following the binding of a co-factor which interacts
with a binding pocket that is formed between the two
lobes of the co-factor binding domain. This putative
binding pocket forms a channel lined with hydro-
phobic amino acids and this would appear to be com-
patible with the binding of fatty acids.
Palmitate induces the expression of acrA
It was reasoned that if palmitate interacts with
BP0983 to relieve repression of acrABC then adding
Figure 3. The role of Acr in resistance to inhibition of growth by small hydrophobic molecules. B. pertussis WT (red), BPΔ0983
(orange), BPacrABCBB (light blue), and BPacrABCBBΔ0983 (dark blue) were grown in SS broth overnight and seeded into 96-well
plates with various concentrations of acriflavine (a), palmitate (b), myristate (c), dodecanoate (d), and oleate (e). Plates were incu-
bated at 37°C for 48 h after which OD600 was measured. The OD600 for each strain was represented as a percent of the OD600 of
untreated samples. Only BPacrABCBBΔ0983 was resistant to acriflavine at ≥8 µg/ml. BPacrABCBB and BPacrABCBBΔ0983 were resist-
ant to higher levels of fatty acids than either WT or BPΔ0983. The data is based on three independent experiments. Error bars rep-
resent standard deviation and significance was determined by 2-way ANOVA.
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palmitate to B. pertussis would be expected to
increase the expression of the locus. To test this,
the transcription of acrA was determined by RT-
qPCR. Cultures of WT were grown in the presence
of heptakis to sequester palmitate produced during
growth that might derepress transcription of acrA
in all samples. Bacteria were diluted into fresh SS
broth or SS broth supplemented with palmitic
acid (16 µg/ml) and after incubation for 1 h RNA
was extracted for RT-qPCR analyses (Figure 5).
Relative to the level of expression of the housekeep-
ing gene, recA, the expression of acrA increased
4.5-fold in the presence of palmitate (p = 0.0302)
(Figure 5). This is consistent with palmitate inter-
acting with BP0983 to relieve repression of acrABC
transcription. In the control culture without palmi-
tate, the expression of acrA decreased slightly
during the hour of incubation, suggesting that
even in the presence of heptakis, in the original
culture some free palmitate caused a slight dere-
pression of transcription, but that diluting the bac-
teria into fresh SS broth in which there was no
palmitate led to full repression and thus a decrease
in transcription of acrA. There was no significant
change in the expression of BP0983 either in the
presence or absence of palmitate (Figure 5),
demonstrating that the change in transcription of
acrA was not due to a change in the level of the
repressor itself.
Discussion
The role of AcrAB-TolC as an efflux pump of hydro-
phobic molecules with an emphasis on its role in anti-
microbial resistance [26–28] has been described. This
study reveals that Bordetella AcrABC is as a non-
specific efflux pump of small hydrophobic molecules.
Intriguingly, B. pertussis has suffered two deletions, in
acrA and cusC (that we have referred to as acrC) that
results in a reduction in activity of B. pertussis AcrABC
leading to an increase in sensitivity to ampicillin,
acriflavine and fatty acids. However, B. pertussis
AcrABC retains low level function rather than being
non-functional, as a strain from which the locus was
deleted accumulated more ethidium bromide than
WT, and in SS in the absence of heptakis this strain
grew less than WT, consistent with increased sensi-
tivity to inhibitory compounds present in the growth
media. B. bronchiseptica-derived AcrABC demon-
strated significantly greater activity than the
B. pertussis system, revealing that it is active against
acriflavine, ampicillin but particularly fatty acids. A
transcriptional repressor controls the expression of
Bordetella acrABC and we show data consistent with
palmitate interacting with the repressor to control its
activity, such that B. pertussis senses palmitate to
increase the expression of an efflux pump that protects
the cell from the inhibitory effect of the fatty acid. It is
logical for the Bordetella to possess an efflux system
that protects them from the effects of free fatty acids
Figure 4. Modelling the structure of BP0983 identifies a putative hydrophobic channel. (a) A model of the structure of the LysR
transcriptional regulator, BP0983, using I-Tasser (default settings), based on a number of similar proteins including CrgA (PDB:
3hhgE) [22], with a C-score of 0.65. The structure comprises a helix-turn-helix DNA binding domain (blue), a hinge domain (purple),
and two co-factor binding domains (green and red). The LysR co-factor binding site is found between the two co-factor binding
domains. (b) Mapping of hydrophobic amino acids (red) reveals that the co-factor binding region contains a channel lined by hydro-
phobic amino acids that could be compatible with binding fatty acids such as palmitate.
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that they secrete during their growth, the reason for
which is unknown. However, it is unclear why
B. pertussis has evolved to possess a poorly functional
AcrABC efflux system that appears to render the
organism highly susceptible to the palmitate that it
secretes. It is possible that palmitate secretion is an
artefact of growth in vitro. Alternatively, B. pertussis
may secrete palmitate but in its natural niche, the
human respiratory tract, the palmitate does not build
to levels that are inhibitory. In other bacteria, high
levels of Acr expression can result in excretion of
metabolites, resulting in growth inhibition of the
organism [29]. Thus the low activity AcrABCBP may
provide sufficient protection from hydrophobic mol-
ecules within its niche, but prevent excretion of impor-
tant metabolites. B. parapertussis is thought to have
evolved, like B. pertussis, from a B. bronchiseptica-like
ancestor to become a cause of whooping cough in
people and restricted to the human respiratory tract
as its sole niche, although there appears to be an
ovine-associated lineage of B. parapertussis distinct to
the human-associated strains. Examination of
B. parapertussis genome sequences reveals that these
bacteria contain the full-length acrABC locus that is
over 99% identical to acrABCBB at the nucleotide
level and thus, like B. bronchiseptica, contains a high-
activity efflux system. Thus the evolution of a low-
activity AcrABC appears to be specific to B. pertussis
and its unique pathogenicity and understanding will
contribute to deciphering this important host–patho-
gen interaction.
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